FDA Adverse Event Injury Summary report: N

OPTILUME BPH CATHETER SYSTEM

MDR report key: 20164166 · Received September 6, 2024

Report

Report Number
3015228875-2024-00003
Event Type
Injury
Date Received
September 6, 2024
Date of Event
August 6, 2024
Report Date
September 6, 2024
Manufacturer
UROTRONIC INC.
Product Code
QXB
PMA / PMN Number
P220029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ANY REQUIRED FIELDS THAT ARE BLANK ARE DUE TO INFORMATION THAT IS CURRENTLY UNKNOWN OR UNAVAILABLE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

ON AUGUST 6, 2024, UROTRONIC WAS MADE AWARE OF A PATIENT TREATED WITH BPH CATHETER SYSTEM ON (B)(6) 2024. THE PATIENT COMPLAINED TO THE TREATING PHYSICIAN OF BLEEDING/HEMATURIA DURING RECOVERY. BETWEEN (B)(6) 2024, THE PHYSICIAN DECIDED TO BRING THE PATIENT TO THE OR FOR CLOT EVACUATION AND FULGURATION. NO PERMANENT SEQUELAE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1302591 OPTILUME BPH CATHETER SYSTEM BPH CATHETER SYSTEM QXB UROTRONIC INC. 1189

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention